Atlas Trials

Rituximab for Patients With Relapsed Acute Lymphoblastic Leukemia

Clinical trial NCT01230788 · TERMINATED

Trial details

NCT number
NCT01230788
Sponsor
Emory University
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
LeukemiaAcute Lymphoblastic LeukemiaALL
Start date
2010-09-01
Primary completion
2012-10-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.